Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
Abstract Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investiga...
Saved in:
Main Authors: | Ji-Hye Park, Chungkwon Yoo, Hyun Woo Chung, Yong Yeon Kim |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/6a3d5f284a7a4d8ca7d71bae717c817a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
No differences in central corneal thickness between open-angle and pseudoexfoliation glaucoma patients
by: Ayala M, et al.
Published: (2017) -
Clinical Analysis of Macular Choroidal Thickness in Pseudoexfoliative Glaucoma and Primary Open-Angle Glaucoma
by: Fan Li, et al.
Published: (2021) -
Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
by: Oghenowede Eyawo, et al.
Published: (2009) -
A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography
by: Yun Ji Lee, et al.
Published: (2021) -
Comparative Study of Lamina Cribrosa Thickness Between Primary Angle-Closure and Primary Open-Angle Glaucoma
by: Wanichwecharungruang B, et al.
Published: (2021)